[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Analgesics in Peru

November 2020 | 25 pages | ID: A09B04EE640EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
As a result of the rumours about the negative impact of ibuprofen on consumers with COVID-19, sales of ibuprofen will see a significant drop in 2020. This comes on top of a slow year for ibuprofen sales in 2019, when DIGEMID warned against the use of ibuprofen, as it was believed that it could result in serious infectious complications. The regulator recommended that health professionals should instead consider using paracetamol in the case of pain and/or fever and prescribe and use any non-ste...

Euromonitor International's Analgesics in Peru report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
KEY DATA FINDINGS
2020 IMPACT
Headaches for suppliers of ibuprofen in 2020, as consumers avoid these products over COVID-19 fears
Panadol continues to lead in analgesics in 2020, with Kitadol also seeing strong growth
Analgesics continues to be helped by high levels of self-medication in 2020
RECOVERY AND OPPORTUNITIES
Brand loyalty will be increasingly important into forecast period
Branded players will fight back against strengthening private label
Changes for generic analgesics expected into forecast period
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources


More Publications